Redmile as of March 31, 2016
Portfolio Holdings for Redmile
Redmile holds 47 positions in its portfolio as reported in the March 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Amicus Therapeutics (FOLD) | 9.3 | $91M | 11M | 8.45 | |
| Medivation | 8.4 | $82M | 1.8M | 45.98 | |
| Clovis Oncology | 6.1 | $60M | 3.1M | 19.20 | |
| Penumbra (PEN) | 6.0 | $58M | 1.3M | 46.00 | |
| Array BioPharma | 5.8 | $57M | 19M | 2.95 | |
| Ironwood Pharmaceuticals (IRWD) | 4.8 | $47M | 4.3M | 10.94 | |
| Atara Biotherapeutics | 4.4 | $43M | 2.3M | 19.03 | |
| BioMarin Pharmaceutical (BMRN) | 4.0 | $39M | 478k | 82.48 | |
| Seattle Genetics | 3.5 | $34M | 970k | 35.09 | |
| Sage Therapeutics (SAGE) | 3.5 | $34M | 1.1M | 32.06 | |
| Allergan | 3.1 | $31M | 114k | 268.03 | |
| Intra Cellular Therapies (ITCI) | 3.0 | $29M | 1.1M | 27.80 | |
| Centene Corporation (CNC) | 3.0 | $29M | 471k | 61.57 | |
| Nanostring Technologies (NSTGQ) | 2.9 | $28M | 1.9M | 15.22 | |
| Boston Scientific Corporation (BSX) | 2.6 | $25M | 1.3M | 18.81 | |
| Brookdale Senior Living (BKD) | 2.3 | $23M | 1.4M | 15.88 | |
| Aetna | 2.2 | $22M | 192k | 112.35 | |
| Molina Healthcare (MOH) | 2.2 | $21M | 329k | 64.49 | |
| Endologix | 2.1 | $21M | 2.5M | 8.36 | |
| Model N (MODN) | 2.1 | $20M | 1.9M | 10.77 | |
| Portola Pharmaceuticals | 1.9 | $18M | 890k | 20.40 | |
| Wave Life Sciences (WVE) | 1.7 | $17M | 1.2M | 13.70 | |
| Neuroderm Ltd F | 1.7 | $17M | 1.2M | 14.12 | |
| Incyte Corporation (INCY) | 1.6 | $16M | 217k | 72.47 | |
| VCA Antech | 1.2 | $12M | 208k | 57.69 | |
| Clovis Oncology | 1.2 | $12M | 600k | 19.20 | |
| Cytomx Therapeutics (CTMX) | 1.0 | $9.4M | 730k | 12.90 | |
| Oxford Immunotec Global | 0.9 | $8.7M | 876k | 9.91 | |
| Conformis | 0.9 | $8.5M | 792k | 10.75 | |
| Charles River Laboratories (CRL) | 0.8 | $8.3M | 110k | 75.94 | |
| Nevro (NVRO) | 0.8 | $7.3M | 131k | 56.26 | |
| HeartWare International | 0.7 | $6.7M | 215k | 31.42 | |
| Invitae (NVTAQ) | 0.7 | $6.8M | 660k | 10.23 | |
| Press Ganey Holdings | 0.7 | $6.6M | 218k | 30.08 | |
| Gw Pharmaceuticals Plc ads | 0.6 | $5.9M | 82k | 72.15 | |
| eHealth (EHTH) | 0.4 | $4.0M | 422k | 9.39 | |
| Pfizer (PFE) | 0.4 | $3.7M | 124k | 29.64 | |
| Syndax Pharmaceuticals (SNDX) | 0.4 | $3.5M | 263k | 13.32 | |
| Array Biopharma Inc note 3.000% 6/0 | 0.3 | $3.2M | 4.0M | 0.80 | |
| DURECT Corporation | 0.3 | $3.1M | 2.3M | 1.35 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 0.3 | $2.7M | 553k | 4.88 | |
| Fate Therapeutics (FATE) | 0.3 | $2.7M | 1.5M | 1.80 | |
| iShares Dow Jones US Health Care (IHF) | 0.1 | $551k | 4.5k | 121.90 | |
| Blueprint Medicines (BPMC) | 0.1 | $488k | 27k | 18.04 | |
| Aurinia Pharmaceuticals (AUPH) | 0.0 | $58k | 20k | 2.94 | |
| Axovant Sciences | 0.0 | $115k | 10k | 11.50 | |
| Chemocentryx | 0.0 | $25k | 10k | 2.50 |
